Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 17, 1982 - Issue 5
Submit an article Journal homepage
20
Views
39
CrossRef citations to date
0
Altmetric
Original Article

Different Effects of Chenodeoxycholic Acid and Ursodeoxycholic Acid on Serum Lipoprotein Concentrations in Patients with Radiolucent Gallstones

O. Leiss Dept. of Medicine, University of Bonn, Bonn-Venusberg, FRG
&
K. von Bergmann Dept. of Medicine, University of Bonn, Bonn-Venusberg, FRG
Pages 587-592 | Received 17 Jul 1981, Accepted 18 Dec 1981, Published online: 19 Feb 2010

Citations (39)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Thierry Claudel, Ekkehard Sturm, Folkert Kuipers & Bart Staels. (2004) The farnesoid X receptor: a novel drug target?. Expert Opinion on Investigational Drugs 13:9, pages 1135-1148.
Read now

Articles from other publishers (38)

Kai Wang, Martin Yan-Chun Chan, Jian Xu, Pik-Shan Li, Xing Liu, Angus Yiu-Fai Lee, Susanna Sau-Tuen Lee & Wing-Tai Cheung. (2020) Male-biased fasting-induced changes in hepatic tauro-cholic acid and plasma cholesterol in Sult2a8-haplodeficient mice. Transgenic Research 29:5-6, pages 499-510.
Crossref
Zhangbin Liao, Bo Sun, Qinggong Zhang, Linlin Jia, Yuliang Wei, Mengqing Liang & Houguo Xu. (2020) Dietary bile acids regulate the hepatic lipid homeostasis in tiger puffer fed normal or high-lipid diets. Aquaculture 519, pages 734935.
Crossref
Zhou-Yi Wu, Hu Li, Jian-Rui Li, Xiao-Qin Lv, Jian-Dong Jiang & Zong-Gen Peng. (2019) Farnesoid X receptor agonist GW4064 indirectly inhibits HCV entry into cells via down-regulating scavenger receptor class B type I. European Journal of Pharmacology 853, pages 111-120.
Crossref
Dong-Ju Shin & Li Wang. 2019. Bile Acids and Their Receptors. Bile Acids and Their Receptors 51 72 .
Vittoria Massafra & Saskia W.C. van Mil. (2018) Farnesoid X receptor: A “homeostat” for hepatic nutrient metabolism. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1864:1, pages 45-59.
Crossref
Emmanuelle Martinot, Lauriane Sèdes, Marine Baptissart, Jean-Marc Lobaccaro, Françoise Caira, Claude Beaudoin & David H. Volle. (2017) Bile acids and their receptors. Molecular Aspects of Medicine 56, pages 2-9.
Crossref
Line Zurkinden, Yosef T. Mansour, Beatrice Rohrbach, Bruno Vogt, Hiten D. Mistry & Geneviève Escher. (2016) Hepatic caveolin‐1 is enhanced in Cyp27a1/ApoE double knockout mice . FEBS Open Bio 6:10, pages 1025-1035.
Crossref
Claire Mazuy, Audrey Helleboid, Bart Staels & Philippe Lefebvre. (2014) Nuclear bile acid signaling through the farnesoid X receptor. Cellular and Molecular Life Sciences 72:9, pages 1631-1650.
Crossref
Changtao Jiang, Cen Xie, Fei Li, Limin Zhang, Robert G. Nichols, Kristopher W. Krausz, Jingwei Cai, Yunpeng Qi, Zhong-Ze Fang, Shogo Takahashi, Naoki Tanaka, Dhimant Desai, Shantu G. Amin, Istvan Albert, Andrew D. Patterson & Frank J. Gonzalez. (2014) Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease. Journal of Clinical Investigation 125:1, pages 386-402.
Crossref
Janne Prawitt, Sandrine Caron & Bart Staels. (2014) Glucose-lowering effects of intestinal bile acid sequestration through enhancement of splanchnic glucose utilization. Trends in Endocrinology & Metabolism 25:5, pages 235-244.
Crossref
Simona D’Amore, Giuseppe Palasciano & Antonio Moschetta. 2014. A Systems Biology Approach to Study Metabolic Syndrome. A Systems Biology Approach to Study Metabolic Syndrome 27 61 .
Thomas Gautier, Willeke de Haan, Jacques Grober, Dan Ye, Matthias J. Bahr, Thierry Claudel, Niels Nijstad, Theo J.C. Van Berkel, Louis M. Havekes, Michael P. Manns, Stefan M. Willems, Pancras C.W. Hogendoorn, Laurent Lagrost, Folkert Kuipers, Miranda Van Eck, Patrick C.N. Rensen & Uwe J.F. Tietge. (2013) Farnesoid X receptor activation increases cholesteryl ester transfer protein expression in humans and transgenic mice. Journal of Lipid Research 54:8, pages 2195-2205.
Crossref
Geoffrey Porez, Janne Prawitt, Barbara Gross & Bart Staels. (2012) Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease. Journal of Lipid Research 53:9, pages 1723-1737.
Crossref
João Soeiro Teodoro, Anabela Pinto Rolo & Carlos Marques Palmeira. (2011) Hepatic FXR: key regulator of whole-body energy metabolism. Trends in Endocrinology & Metabolism 22:11, pages 458-466.
Crossref
Michele Vacca, Chiara Degirolamo, Renato Mariani‐Costantini, Giuseppe Palasciano & Antonio Moschetta. (2011) Lipid‐sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome. WIREs Systems Biology and Medicine 3:5, pages 562-587.
Crossref
Christophe Gardès, Denise Blum, Konrad Bleicher, Evelyne Chaput, Martin Ebeling, Peter Hartman, Corinne Handschin, Hans Richter & G. Martin Benson. (2011) Studies in mice, hamsters, and rats demonstrate that repression of hepatic apoA-I expression by taurocholic acid in mice is not mediated by the farnesoid-X-receptor. Journal of Lipid Research 52:6, pages 1188-1199.
Crossref
Michael Trauner & Emina Halilbasic. (2011) Nuclear Receptors as New Perspective for the Management of Liver Diseases. Gastroenterology 140:4, pages 1120-1125.e12.
Crossref
Thierry Claudel & Michael Trauner. 2010. Signaling Pathways in Liver Diseases. Signaling Pathways in Liver Diseases 317 332 .
Philippe Lefebvre, Bertrand Cariou, Fleur Lien, Folkert Kuipers & Bart Staels. (2009) Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation. Physiological Reviews 89:1, pages 147-191.
Crossref
Janne Prawitt, Sandrine Caron & Bart Staels. (2009) How to modulate FXR activity to treat the Metabolic Syndrome. Drug Discovery Today: Disease Mechanisms 6:1-4, pages e55-e64.
Crossref
Charles Thomas, Roberto Pellicciari, Mark Pruzanski, Johan Auwerx & Kristina Schoonjans. (2008) Targeting bile-acid signalling for metabolic diseases. Nature Reviews Drug Discovery 7:8, pages 678-693.
Crossref
Bertrand Cariou & Bart Staels. (2007) FXR: a promising target for the metabolic syndrome?. Trends in Pharmacological Sciences 28:5, pages 236-243.
Crossref
Sabine M. PostMartine GroenendijkCaroline C. van der HoogtCatherine FievetGérald LucMenno HoekstraHans M.G. PrincenBart StaelsPatrick C.N. Rensen. (2006) Cholesterol 7α-Hydroxylase Deficiency in Mice on an APOE*3-Leiden Background Increases Hepatic ABCA1 mRNA Expression and HDL-Cholesterol. Arteriosclerosis, Thrombosis, and Vascular Biology 26:12, pages 2724-2730.
Crossref
Salvatore Modica & Antonio Moschetta. (2006) Nuclear bile acid receptor FXR as pharmacological target: Are we there yet?. FEBS Letters 580:23, pages 5492-5499.
Crossref
Sander M Houten, Mitsuhiro Watanabe & Johan Auwerx. (2006) Endocrine functions of bile acids. The EMBO Journal 25:7, pages 1419-1425.
Crossref
Stefan Bilz, Varman Samuel, Katsutaro Morino, David Savage, Cheol Soo Choi & Gerald I. Shulman. (2006) Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters. American Journal of Physiology-Endocrinology and Metabolism 290:4, pages E716-E722.
Crossref
Nada Y. KalaanyDavid J. Mangelsdorf. (2006) LXRS AND FXR: The Yin and Yang of Cholesterol and Fat Metabolism. Annual Review of Physiology 68:1, pages 159-191.
Crossref
David MassonLaurent LagrostAnne AthiasPhilippe GambertCynthia Brimer-ClineLubin LanJohn D. SchuetzErin G. SchuetzMahfoud Assem. (2005) Expression of the Pregnane X Receptor in Mice Antagonizes the Cholic Acid–Mediated Changes in Plasma Lipoprotein Profile. Arteriosclerosis, Thrombosis, and Vascular Biology 25:10, pages 2164-2169.
Crossref
Thierry ClaudelBart StaelsFolkert Kuipers. (2005) The Farnesoid X Receptor. Arteriosclerosis, Thrombosis, and Vascular Biology 25:10, pages 2020-2030.
Crossref
Bertrand Cariou, Daniel Duran-Sandoval, Folkert Kuipers & Bart Staels. (2005) Farnesoid X Receptor: A New Player in Glucose Metabolism?. Endocrinology 146:3, pages 981-983.
Crossref
Thierry Claudel, Yusuke Inoue, Olivier Barbier, Daniel Duran-Sandoval, Vladimir Kosykh, Jamila Fruchart, Jean-Charles Fruchart, Frank J Gonzalez & Bart Staels. (2003) Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression. Gastroenterology 125:2, pages 544-555.
Crossref
Thierry Claudel, Ekkehard Sturm, Hélène Duez, Inés Pineda Torra, Audrey Sirvent, Vladimir Kosykh, Jean-Charles Fruchart, Jean Dallongeville, Dean W. Hum, Folkert Kuipers & Bart Staels. (2002) Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element. Journal of Clinical Investigation 109:7, pages 961-971.
Crossref
Marie A. Abate. (2016) Medical Management of Cholesterol Gallstones. Drug Intelligence & Clinical Pharmacy 20:2, pages 106-115.
Crossref
M. C. Bateson. 1986. Gallstone Disease and its Management. Gallstone Disease and its Management 229 241 .
Gianfranco Salvioli, Ruggero Lugli & John M. Pradelli. (1985) Cholesterol absorption and sterol balance in normal subjects receiving dietary fiber or ursodeoxycholic acid. Digestive Diseases and Sciences 30:4, pages 301-307.
Crossref
Serge Erlinger, Alice Le Go, Jean-Marc Husson & Johan Fevery. (1984) Franco-Belgian Cooperative Study of Ursodeoxycholic Acid in the Medical Dissolution of Gallstones: A Double-Blind, Randomized, Dose-Response Study, and Comparison with Chenodeoxycholic Acid. Hepatology 4:2, pages 308-314.
Crossref
Ottmar Lei� & Klaus Bergmann. (1983) Zusammenh�nge zwischen Serum-Lipoproteinstoffwechsel und bili�rem LipidstoffwechselInterrelationships between serum lipoprotein metabolism and biliary lipid metabolism. Klinische Wochenschrift 61:12, pages 579-592.
Crossref
O. Leiß & K. Von Bergmann. (1983) Wechselwirkungen zwischen Lipoproteinstoffwechsel im Serum und Lipidstoffwechsel in der Galle. Fette, Seifen, Anstrichmittel 85:S2, pages 603-608.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.